Literature DB >> 2060089

HDL, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men.

J T Salonen1, R Salonen, K Seppänen, R Rauramaa, J Tuomilehto.   

Abstract

BACKGROUND: We investigated the association of cholesterol concentrations in serum high density lipoprotein (HDL) and its subfractions HDL2 and HDL3 with the risk of acute myocardial infarction in 1,799 randomly selected men 42, 48, 54, or 60 years old. METHODS AND
RESULTS: Baseline examinations in the Kuopio Ischaemic Heart Disease Risk Factor Study were done during 1984-1987. In Cox multivariate survival models adjusted for age and examination year, serum HDL cholesterol of less than 1.09 mmol/l (42 mg/dl) was associated with a 3.3-fold risk of acute myocardial infarction (95% confidence intervals [CI], 1.7-6.4), serum HDL2, cholesterol of less than 0.65 mmol/l (25 mg/dl) was associated with a 4.0-fold risk of acute myocardial infarction (95% CI, 1.9-8.3), and serum HDL3 cholesterol of less than 0.40 mmol/l (15 mg/dl) was associated with a 2.0-fold (95% CI, 1.1-4.0) risk of acute myocardial infarction. Adjustments for obesity, ischemic heart disease, other cardiovascular disease, maximal oxygen uptake, systolic blood pressure, antihypertensive medication, serum low density lipoprotein cholesterol, and triglyceride concentrations reduced the excess risks associated with serum HDL, HDL2, and HDL3 cholesterol in the lowest quartiles by 52%, 48%, and 41%, respectively. Additional adjustments for alcohol consumption, cigarettes smoked daily, smoking years, and leisure time energy expenditure reduced these excess risks associated with low HDL, HDL2, and HDL3 cholesterol levels by another 26%, 24% and 21%, respectively.
CONCLUSIONS: Our data confirm that both total HDL and HDL2 levels have inverse associations with the risk of acute myocardial infarction and may thus be protective factors in ischemic heart disease, whereas the role of HDL3 remains equivocal.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2060089     DOI: 10.1161/01.cir.84.1.129

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  79 in total

1.  Polymorphism in high density lipoprotein paraoxonase gene and risk of acute myocardial infarction in men: prospective nested case-control study.

Authors:  J T Salonen; R Malin; T P Tuomainen; K Nyyssönen; T A Lakka; T Lehtimäki
Journal:  BMJ       Date:  1999-08-21

2.  The EUROSTROKE cohorts: a short description and data analytical approach.

Authors:  M L Bots; P C Elwood; Y Nikitin; J T Salonen; A Freire de Concalves; D Inzitari; J Sivenius; A Trichopoulou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

3.  Direct measurement of HDL cholesterol: method eliminating apolipoprotein E-rich particles.

Authors:  M Okada; H Matsui; Y Ito; A Fujiwara
Journal:  J Clin Lab Anal       Date:  2001       Impact factor: 2.352

4.  Liver damage and protective effect of high density lipoprotein cholesterol.

Authors:  Jukka T Salonen
Journal:  BMJ       Date:  2003-11-08

Review 5.  High-density lipoprotein subfractions and risk of coronary artery disease.

Authors:  John Morgan; Christina Carey; Anne Lincoff; David Capuzzi
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113

6.  Separation of the principal HDL subclasses by iodixanol ultracentrifugation.

Authors:  Nicola L Harman; Bruce A Griffin; Ian G Davies
Journal:  J Lipid Res       Date:  2013-05-20       Impact factor: 5.922

7.  Biochemical and functional characterization of charge-defined subfractions of high-density lipoprotein from normal adults.

Authors:  Ju-Yi Hsieh; Chiz-Tzung Chang; Max T Huang; Chia-Ming Chang; Chia-Ying Chen; Ming-Yi Shen; Hsin-Yi Liao; Guei-Jane Wang; Chu-Huang Chen; Chao-Jung Chen; Chao-Yuh Yang
Journal:  Anal Chem       Date:  2013-11-13       Impact factor: 6.986

8.  Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?

Authors:  K G M Moons; M L Bots; J T Salonen; P C Elwood; A Freire de Concalves; Y Nikitin; J Sivenius; D Inzitari; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

9.  Alterations in the high density lipoprotein phenotype and HDL-associated enzymes in subjects with metabolic syndrome.

Authors:  K G Lagos; T D Filippatos; V Tsimihodimos; I F Gazi; C Rizos; A D Tselepis; D P Mikhailidis; Moses S Elisaf
Journal:  Lipids       Date:  2008-10-28       Impact factor: 1.880

10.  Do HDL and LDL subfractions play a role in atherosclerosis in end-stage renal disease (ESRD) patients?

Authors:  Anna Gluba-Brzózka; Beata Franczyk; Maciej Banach; Magdalena Rysz-Górzyńska
Journal:  Int Urol Nephrol       Date:  2016-12-09       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.